The hyperphosphorylation of tau is associated with a transition of tau from a predominantly soluble, lower molecular weight species to a predominantly insoluble, higher molecular weight species, a transition that is thought to be intimately associated with the development of tauopathy and neurodegeneration [2]. The gene discussed is MAPT; the disease is tauopathy.